Diana Whitehead

736 total citations
10 papers, 276 citations indexed

About

Diana Whitehead is a scholar working on Epidemiology, Surgery and Genetics. According to data from OpenAlex, Diana Whitehead has authored 10 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Surgery and 5 papers in Genetics. Recurrent topics in Diana Whitehead's work include Microscopic Colitis (5 papers), Inflammatory Bowel Disease (5 papers) and Eosinophilic Esophagitis (2 papers). Diana Whitehead is often cited by papers focused on Microscopic Colitis (5 papers), Inflammatory Bowel Disease (5 papers) and Eosinophilic Esophagitis (2 papers). Diana Whitehead collaborates with scholars based in United States. Diana Whitehead's co-authors include Brian E. Lacy, Corey A. Siegel, Arun Swaminath, Parambir S. Dulai, Siddharth Singh, Eugenia Shmidt, Edward V. Loftus, David Hudesman, Sunanda V. Kane and Xiaoqian Jiang and has published in prestigious journals such as Gastroenterology, The American Journal of Gastroenterology and Current Gastroenterology Reports.

In The Last Decade

Diana Whitehead

10 papers receiving 270 citations

Peers

Diana Whitehead

GENET

EPIDE

SURGE

IMMUN

GASTR

Yoon‐Kyo An Australia

Zachary Zator United States

Laura Armengol‐Debeir France

Aurada Cholapranee United States

Lieven Vandeputte Belgium

Philip Jenkinson United Kingdom

Elisabeth Evans United States

Sónia Bernardo Portugal

Clotilde Baudry France

Khadija Chaudrey United States

Yoon‐Kyo An Australia

Diana Whitehead

224 ×1.1

GENET

179 ×1.0

EPIDE

140 ×1.2

SURGE

53 ×1.0

IMMUN

17 ×0.6

GASTR

Citations per year, relative to Diana Whitehead Diana Whitehead (= 1×) peers Yoon‐Kyo An

Countries citing papers authored by Diana Whitehead

Since Specialization

Citations

This map shows the geographic impact of Diana Whitehead's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana Whitehead with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana Whitehead more than expected).

Fields of papers citing papers by Diana Whitehead

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diana Whitehead. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana Whitehead. The network helps show where Diana Whitehead may publish in the future.

Co-authorship network of co-authors of Diana Whitehead

This figure shows the co-authorship network connecting the top 25 collaborators of Diana Whitehead. A scholar is included among the top collaborators of Diana Whitehead based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diana Whitehead. Diana Whitehead is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Dulai, Parambir S., Siddharth Singh, Xiaoqian Jiang, et al.. (2016). The Real-World Effectiveness and Safety of Vedolizumab for Moderate–Severe Crohn’s Disease: Results From the US VICTORY Consortium. The American Journal of Gastroenterology. 111(8). 1147–1155. 216 indexed citations

2.

Dulai, Parambir S., Farhad Peerani, Neeraj Narula, et al.. (2016). Sa1889 Efficacy and Predictors of Outcomes of Vedolizumab for Crohn's Disease in Clinical Practice. Gastroenterology. 150(4). S393–S393. 1 indexed citations

3.

Peerani, Farhad, Neeraj Narula, Parambir S. Dulai, et al.. (2016). Sa1888 Efficacy and Predictors of Outcomes of Vedolizumab for Ulcerative Colitis in Clinical Practice. Gastroenterology. 150(4). S392–S393. 2 indexed citations

4.

Chaudrey, Khadija, Diana Whitehead, Parambir S. Dulai, et al.. (2016). Tu1908 Safety of Vedolizumab in Inflammatory Bowel Disease in a Multi-Center Real World Consortium. Gastroenterology. 150(4). S974–S974. 3 indexed citations

5.

Shah, Shawn L., Diana Whitehead, Kartik Sampath, & Arifa Toor. (2015). A Case of Clostridium septicum Aortitis With Concomitant Adenocarcinoma of the Cecum. ACG Case Reports Journal. 2(1). 230–232. 8 indexed citations

6.

Whitehead, Diana, Prabhjot Kaur, & Arifa Toor. (2015). Diffuse Large B-Cell Lymphoma of Recto-Sigmoid Colon. The American Journal of Gastroenterology. 110. S146–S146. 1 indexed citations

7.

Dulai, Parambir S., Siddharth Singh, Neeraj Narula, et al.. (2015). Vedolizumab for Moderate to Severely Active Inflammatory Bowel Disease: A Multicenter U.S. Consortium. The American Journal of Gastroenterology. 110. S809–S809. 1 indexed citations

8.

Whitehead, Diana & Timothy B. Gardner. (2014). Evidence-Based Management of Necrotizing Pancreatitis. Current Treatment Options in Gastroenterology. 12(3). 322–332. 2 indexed citations

9.

Whitehead, Diana, et al.. (2014). Fecal Impaction. Current Gastroenterology Reports. 16(9). 404–404. 36 indexed citations

10.

Palmer, Joy, et al.. (1996). Performance through people. 4(4). 23–27. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact